Decontamination of the digestive tract and oropharynx in ICU patients

The New England Journal of Medicine
A M G A de SmetM J M Bonten

Abstract

Selective digestive tract decontamination (SDD) and selective oropharyngeal decontamination (SOD) are infection-prevention measures used in the treatment of some patients in intensive care, but reported effects on patient outcome are conflicting. We evaluated the effectiveness of SDD and SOD in a crossover study using cluster randomization in 13 intensive care units (ICUs), all in The Netherlands. Patients with an expected duration of intubation of more than 48 hours or an expected ICU stay of more than 72 hours were eligible. In each ICU, three regimens (SDD, SOD, and standard care) were applied in random order over the course of 6 months. Mortality at day 28 was the primary end point. SDD consisted of 4 days of intravenous cefotaxime and topical application of tobramycin, colistin, and amphotericin B in the oropharynx and stomach. SOD consisted of oropharyngeal application only of the same antibiotics. Monthly point-prevalence studies were performed to analyze antibiotic resistance. A total of 5939 patients were enrolled in the study, with 1990 assigned to standard care, 1904 to SOD, and 2045 to SDD; crude mortality in the groups at day 28 was 27.5%, 26.6%, and 26.9%, respectively. In a random-effects logistic-regression mode...Continue Reading

References

Sep 1, 1971·The Journal of Hygiene·D van der Waaij Lekkerkerk Lekkerkerk-v
Dec 31, 1997·American Journal of Respiratory and Critical Care Medicine·M Garrouste-OrgeasB Schlemmer
Aug 12, 1998·The Journal of Hospital Infection·W LingnauH Benzer
Aug 14, 2001·American Journal of Respiratory and Critical Care Medicine·D C BergmansE E Stobberingh
Jun 20, 2003·Lancet·Jean-Louis Vincent
Dec 31, 2003·Lancet·Marc J M BontenArno Hoes
Mar 20, 2004·BMJ : British Medical Journal·Marion K CampbellUNKNOWN CONSORT group
Apr 20, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Marc J M BontenJesse B Hall
Feb 9, 2005·American Journal of Respiratory and Critical Care Medicine·UNKNOWN American Thoracic Society, UNKNOWN Infectious Diseases Society of America
Apr 11, 2006·American Journal of Respiratory and Critical Care Medicine·Mirelle KoemanMarc J M Bonten
Aug 10, 2006·Intensive Care Medicine·Alexandra HeiningerWolfgang A Krueger
Dec 6, 2006·Intensive Care Medicine·C P StoutenbeekUNKNOWN Working Group on Selective Decontamination of the Digestive Tract

❮ Previous
Next ❯

Citations

Apr 21, 2010·Der Anaesthesist·M BernhardM A Weigand
Jan 29, 2011·Der Anaesthesist·T Perl, M Quintel
Apr 6, 2013·Der Anaesthesist·J BriegelUNKNOWN Surviving Sepsis Campaign
Aug 20, 2010·Intensive Care Medicine·Guy J OudhuisAnnelies Verbon
Feb 2, 2012·Intensive Care Medicine·Evelien A N OostdijkMarc J M Bonten
Jan 31, 2013·Intensive Care Medicine·R P DellingerUNKNOWN Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup
Jan 5, 2013·Intensive Care Medicine·Christian Brun-BuissonMarc J M Bonten
Jul 3, 2013·Intensive Care Medicine·Emilio BouzaPatricia Muñoz
Sep 13, 2011·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A van Eck van der SluijsEdgar J G Peters
Nov 1, 2012·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M F EngelJ J Oosterheert
Dec 27, 2012·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·C Angebault, A Andremont
Aug 21, 2012·Digestive Diseases and Sciences·Kentaro ShimizuHisashi Sugimoto
Aug 25, 2009·Current Infectious Disease Reports·John Dallas, Marin Kollef
Mar 15, 2011·Current Infectious Disease Reports·Oleksa Rewa, John Muscedere
Apr 7, 2011·Neurocritical Care·Martine E Bos EyssenMathieu van der Jagt
May 18, 2013·Australian Critical Care : Official Journal of the Confederation of Australian Critical Care Nurses·Stephan U DombrowskiUNKNOWN SuDDICU UK Study Group
Oct 29, 2013·Best Practice & Research. Clinical Gastroenterology·Nicolien J SchepersUNKNOWN Dutch Pancreatitis Study Group
Aug 24, 2013·The Lancet Infectious Diseases·James C Hurley
Aug 24, 2013·The Lancet Infectious Diseases·Bastiaan H J WittekampMarc J M Bonten
Aug 24, 2013·The Lancet Infectious Diseases·Nick DanemanBrian H Cuthbertson
Mar 3, 2011·Nature Reviews. Nephrology·Zaccaria RicciClaudio Ronco
May 15, 2009·The New England Journal of Medicine·Nico E MeessenMaarten P Andriessen
Jan 28, 2011·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Francisco AbecasisHendrik K F van Saene
Aug 24, 2013·Surgical Infections·Simonetta FranchelliAndrea De Maria
Jan 1, 2011·Therapeutic Hypothermia and Temperature Management·Mary Kay Bader
May 20, 2014·Therapeutic Hypothermia and Temperature Management
Feb 18, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Michael Y Lin, Marc J M Bonten
Sep 20, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Matthieu SchmidtAlain Combes
Mar 16, 2011·The Journal of Antimicrobial Chemotherapy·John R ProwleMervyn Singer
May 31, 2012·The Journal of Antimicrobial Chemotherapy·Evelien A N OostdijkUNKNOWN Dutch SOD-SDD Trialists Group
Jun 26, 2009·Critical Care Medicine·Kees H Polderman
Nov 3, 2010·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Vani VenkatachalamDouglas F Willson
Jul 19, 2012·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Andy PetrosHendrick van Saene
May 1, 2013·Antimicrobial Agents and Chemotherapy·Teysir HalabyChristina M J E Vandenbroucke-Grauls
Apr 18, 2013·Journal of Clinical Microbiology·L SilvestriH K F van Saene

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.